Charles River has acquired BRASS Pte Ltd, an ISO 17025 accredited microbiology subcontract test laboratory specializing in endotoxin testing, bacterial and fungal identification of environmental isolates, sterilization validation, microbial quality control analysis and lot release testing of biopharmaceutical, pharmaceutical and medical device products.

This is the second purchase by Charles River of a laboratory business since 2012 and will help to accelerate the growth of its portfolio of products and services in Asia by providing clients with state-of-the-art microbial detection and identification for manufacturing in the biopharmaceutical, medical device and life sciences industries.